Hypercalcemia disease
Pro Research Analysisby 
Searched over 200M research papers for "hypercalcemia disease"
Hypercalcemia Disease: Causes, Pathophysiology, and Treatment
Overview of Hypercalcemia
Hypercalcemia is a condition characterized by elevated levels of calcium in the blood. It affects approximately 1% of the global population and can range from mild to severe, with varying symptoms and underlying causes . The condition is often associated with primary hyperparathyroidism and malignancies, but other causes include granulomatous diseases, endocrinopathies, genetic disorders, and certain medications .
Causes of Hypercalcemia
Malignancy-Associated Hypercalcemia
Hypercalcemia of malignancy is a common complication in cancer patients, affecting up to 20% of individuals with cancer . It is frequently seen in patients with multiple myeloma, leukemia, non-Hodgkin's lymphoma, and solid tumors such as breast and renal carcinomas . The majority of cases are due to the production of parathyroid hormone-related protein (PTHrP) by the tumor, which increases bone resorption and renal calcium reabsorption 16. In some cases, direct bone metastasis and ectopic production of calcitriol also contribute to hypercalcemia 16.
Primary Hyperparathyroidism
Primary hyperparathyroidism (PHPT) is another leading cause of hypercalcemia, accounting for a significant proportion of cases . It is characterized by the overproduction of parathyroid hormone (PTH), which increases calcium levels by promoting bone resorption, increasing intestinal calcium absorption, and reducing renal calcium excretion .
Vitamin D-Mediated Hypercalcemia
Excessive intake of vitamin D or its analogs can lead to hypercalcemia by increasing intestinal calcium absorption and reducing its renal excretion . This form of hypercalcemia is also seen in granulomatous diseases like sarcoidosis and tuberculosis, where ectopic production of 1,25-dihydroxyvitamin D by macrophages or tumor cells occurs .
Genetic and Rare Causes
Genetic mutations can also lead to hypercalcemia. For instance, familial hypocalciuric hypercalcemia is caused by mutations in the calcium-sensing receptor gene . Other rare causes include milk-alkali syndrome, immobilization, and certain medications like thiazide diuretics .
Pathophysiology of Hypercalcemia
The pathophysiology of hypercalcemia involves multiple mechanisms, including increased bone resorption, enhanced renal calcium reabsorption, and increased intestinal calcium absorption 26. In malignancy-associated hypercalcemia, systemic mediators like PTHrP and local factors such as cytokines play a crucial role in increasing osteoclast activity and bone resorption 610. In primary hyperparathyroidism, elevated PTH levels directly stimulate these processes .
Clinical Manifestations
The symptoms of hypercalcemia vary depending on the severity and rapidity of calcium elevation. Mild hypercalcemia is often asymptomatic but can cause fatigue and constipation in some individuals . Severe hypercalcemia can lead to nausea, vomiting, dehydration, confusion, and even coma . In children, symptoms may include hypotonia, poor feeding, vomiting, constipation, and in severe cases, renal failure and seizures .
Diagnosis and Treatment
Diagnostic Approaches
The diagnosis of hypercalcemia involves measuring serum calcium levels and determining the underlying cause. Elevated PTH levels indicate primary hyperparathyroidism, while suppressed PTH levels suggest other causes such as malignancy or vitamin D intoxication . Additional tests may include measuring PTHrP, 1,25-dihydroxyvitamin D, and imaging studies to identify bone metastasis or other abnormalities 13.
Treatment Strategies
The treatment of hypercalcemia depends on its severity and underlying cause. Mild cases may not require immediate intervention, while severe cases necessitate prompt treatment to lower serum calcium levels. Initial therapy often includes aggressive hydration and intravenous bisphosphonates to inhibit bone resorption 17. In refractory cases, novel therapies such as denosumab and calcimimetics like cinacalcet may be used . Glucocorticoids are effective in cases of vitamin D-mediated hypercalcemia .
Conclusion
Hypercalcemia is a multifaceted condition with various underlying causes, including malignancies, primary hyperparathyroidism, and vitamin D intoxication. Understanding the pathophysiology and clinical manifestations is crucial for accurate diagnosis and effective treatment. While mild cases may be managed conservatively, severe hypercalcemia requires aggressive intervention to prevent serious complications.
Sources and full results
Most relevant research papers on this topic